Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTaP-Hep B-PRP-T vaccine in healthy infants (Philippines)
NCT00343889Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2006
- Primary completion
- Nov 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of DTaP-HB-PRP~T vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by Sanofi. Started Aug 2006; status: completed.
02
Drugs
DTaP-HB-PRP~T vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00343889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343889.